- Home
- ATTO vs LZB Comparison
ATTO vs LZB Comparison
Compare ATTO & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATTO | LZB |
|---|---|---|
| Founded | 2023 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2026 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ATTO | LZB |
|---|---|---|
| Price | $14.12 | $29.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $42.20 | $41.00 |
| AVG Volume (30 Days) | 416.7K | ★ 575.7K |
| Earning Date | 09-02-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 3.31% |
| EPS Growth | N/A | ★ 5.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,349,433,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.94 | $28.79 |
| 52 Week High | $28.00 | $44.90 |
Technical Indicators
Market Signals| Indicator | ATTO | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 39.43 |
| Support Level | N/A | $28.79 |
| Resistance Level | $18.38 | $39.66 |
| Average True Range (ATR) | 1.18 | 0.68 |
| MACD | -0.23 | 0.23 |
| Stochastic Oscillator | 21.53 | 25.85 |
Price Performance
Historical ComparisonAbout ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.